Ignite Creation Date:
2025-12-24 @ 10:35 PM
Ignite Modification Date:
2025-12-30 @ 1:47 AM
Study NCT ID:
NCT02398435
Status:
COMPLETED
Last Update Posted:
2016-12-06
First Post:
2015-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
Sponsor:
AB2 Bio Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-02
Start Date Type:
None
Primary Completion Date:
2016-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-07
Completion Date Type:
ACTUAL
First Submit Date:
2015-02-23
First Submit QC Date:
None
Study First Post Date:
2015-03-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-05
Last Update Post Date:
2016-12-06
Last Update Post Date Type:
ESTIMATED